We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
SCIEX Launches New X500B QTOF Mass Spectrometry System
Product News

SCIEX Launches New X500B QTOF Mass Spectrometry System

SCIEX Launches New X500B QTOF Mass Spectrometry System
Product News

SCIEX Launches New X500B QTOF Mass Spectrometry System

Credit: SCIEX

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "SCIEX Launches New X500B QTOF Mass Spectrometry System "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SCIEX today announced its latest solution in the X-Series Quadrupole Time of Flight (QTOF) mass spectrometry (MS) platform. The newest X-Series model, the X500B QTOF System, brings simplicity, high performance and robustness for biotherapeutic analyses to one of the most compact MS system footprints on the market. The new user-friendly SCIEX OS Software interface and powerful BioPharmaViewTM 2.0 processing software comprise an unmatched integrated LC-MS solution for mass spec experts, or novices, performing standard biotherapeutic characterisation.

The X500R QTOF System emerged in 2015 as the first LC-MS solution designed specifically for routine food, environmental and forensic testing. It introduced an entirely new industrial design, fully loaded with easy-to-use software, methods and libraries, custom-designed for targeted customer applications. The X500R QTOF has since won awards and achieved accolades from industry-leading laboratories and key opinion leaders.

The X500B QTOF System was specifically developed to deliver ease-of-use for high resolution standardised workflows for biotherapeutic developers, who are required to fully characterise biologic products in large numbers during the development process. Many MS-based workflows require users to be MS system experts who must perform complicated data processing and manual calculations.

The workflows can be complex to set up and involve intensive and sometimes confusing software. The X500B QTOF offers the robust and streamlined, quality instrumentation that SCIEX is known for, with the intuitive SCIEX OS user interface for simplified workflow setup.

To simplify complex data processing, the X500B QTOF System comes with BioPharmaView Software 2.0, enabling scientists to generate better information, faster. BioPharmaView Mass Spec Software also offers the ability to interpret SWATH® 2.0 data independent acquisition on the X500B QTOF System.

SWATH acquisition allows for comprehensive peptide mapping data to be acquired in a single injection, with high-resolution MS and MSMS data for every peptide in the sample. This strategy results in the ability to detect important low-abundance peptides and post-translational modifications that may be missed with other approaches. With the X500B QTOF System, all users can achieve expert level results in their biotherapeutic characterisation workflows.

 “Mass spec users have been asking for systems that are purpose built for their application, and SCIEX has listened,” said Farzana Azam, Senior Director, Pharmaceutical/CRO Business at SCIEX. “The introduction of the X500B System brings a new level of simplicity, robustness and integration to simplify the complex world of biologics characterisation.

The combination of this innovative, true benchtop QTOF system, and software such as SCIEX OS and unique SWATH Acquisition, creates the complete easy-to-use and streamlined solution for standard biologic analyses.”

This article has been republished from materials provided by Sciex. Note: material may have been edited for length and content. For further information, please contact the cited source.


Advertisement